- CFO Spotlights
- Profiles
- Brian Brown
Profile
Brian Brown
Chief Financial Officer (Principal Financial and Accounting Officer), Co-Diagnostics, Inc.
Former. First published here October 28, 2026; built from records as of October 28, 2026.
Co-Diagnostics, Inc. named Daniel Bohrer to succeed Brian Brown, effective September 2, 2026.2
Seats
The seat in the record
| Company | Title as filed | Standing |
|---|---|---|
| Co-Diagnostics, Inc. (CODX) Surgical & Medical Instruments & Apparatus | Chief Financial Officer (Principal Financial and Accounting Officer) | Former |
Company names link to the company's page in the record at CFO Tribune, which holds the seat history.
The record
Filing by filing, latest first
- September 2, 2026effective
Co-Diagnostics, Inc. named Daniel Bohrer to succeed Brian Brown, effective September 2, 2026. Profile of Daniel Bohrer.
[2] Filing by Co-Diagnostics, Inc., filed with the SEC on September 4, 2026. Read the filing. The record at CFO Tribune.
- March 31, 202610-K filed
Brian Brown signed the annual report of Co-Diagnostics, Inc. on Form 10-K as Chief Financial Officer (Principal Financial and Accounting Officer), filed March 31, 2026.
/s/ Brian Brown Chief Financial Officer March 31, 2026 Brian Brown (Principal Financial and Accounting Officer)
[1] Annual report on Form 10-K by Co-Diagnostics, Inc., filed with the SEC on March 31, 2026. Read the filing. The record at CFO Tribune.
Sources
Sources
- Annual report on Form 10-K, Co-Diagnostics, Inc.. U.S. Securities and Exchange Commission, EDGAR, filed March 31, 2026. sec.gov; record.
- Current report filed with the SEC, Co-Diagnostics, Inc.. U.S. Securities and Exchange Commission, EDGAR, filed September 4, 2026. sec.gov; record.
Corrections and removal
If a line here is wrong, or Brian Brown wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.